-
Something wrong with this record ?
Reply to the Letter to the Editor 'Neoadjuvant radiochemotherapy and perioperative chemotherapy does not represent a standard at same priority level for oesophageal adenocarcinomas (in regard to "Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up")' by Cellini et al
R. Obermannová, EC. Smyth, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
Language English Country England, Great Britain
Document type Letter
Persistent link
https://www.medvik.cz/link/bmc23011130
Online
Full text
NLK
Free Medical Journals
from 1996 to 1 year ago
ROAD: Directory of Open Access Scholarly Resources
- MeSH
- Adenocarcinoma * therapy drug therapy MeSH
- Chemoradiotherapy MeSH
- Humans MeSH
- Esophageal Neoplasms * therapy drug therapy MeSH
- Follow-Up Studies MeSH
- Neoadjuvant Therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011130
- 003
- CZ-PrNML
- 005
- 20230801132827.0
- 007
- ta
- 008
- 230718s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.annonc.2023.03.004 $2 doi
- 035 __
- $a (PubMed)37295906
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Obermannová, R $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 245 10
- $a Reply to the Letter to the Editor 'Neoadjuvant radiochemotherapy and perioperative chemotherapy does not represent a standard at same priority level for oesophageal adenocarcinomas (in regard to "Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up")' by Cellini et al / $c R. Obermannová, EC. Smyth, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a neoadjuvantní terapie $7 D020360
- 650 _2
- $a následné studie $7 D005500
- 650 12
- $a adenokarcinom $x terapie $x farmakoterapie $7 D000230
- 650 12
- $a nádory jícnu $x terapie $x farmakoterapie $7 D004938
- 650 _2
- $a chemoradioterapie $7 D059248
- 655 _2
- $a dopisy $7 D016422
- 700 1_
- $a Smyth, E C $u Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
- 710 2_
- $a ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org
- 773 0_
- $w MED00000432 $t Annals of oncology : official journal of the European Society for Medical Oncology $x 1569-8041 $g Roč. 34, č. 6 (2023), s. 554-555
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37295906 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801132823 $b ABA008
- 999 __
- $a ok $b bmc $g 1963496 $s 1197395
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 34 $c 6 $d 554-555 $e 20230505 $i 1569-8041 $m Annals of oncology $n Ann Oncol $x MED00000432
- LZP __
- $a Pubmed-20230718
